Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 5, 2009, Pages 765-770

  Haug, Alexander ^a,b   Auernhammer, Christoph J ^a   Wängler, Björn ^a   Tiling, Reinhold ^a   Schmidt, Gerwin ^b   Göke, Burkhard ^a   Bartenstein, Peter ^a   Pöpperl, Gabriele ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

18F DOPA; 68Ga DOTA TATE; Neuroendocrine tumours; Somatostatin receptors

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTATE[3 TYROSINE] GALLIUM GA 68; 6 FLUORODOPA F 18; GALLIUM 68; OCTREOTIDE[3 TYROSINE]; SEROTONIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; GALLIUM; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR;

ADULT; AGED; APPARATUS; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTESTINE CANCER; LUNG CANCER; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS CANCER; PARANASAL SINUS CANCER; POSITRON EMISSION TOMOGRAPHY; SEROTONIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; DIHYDROXYPHENYLALANINE; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SEROTONIN;

EID: 64649091992     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-1030-8     Document Type: Article

References (12)

1. M Gabriel C Decristoforo D Kendler G Dobrozemsky D Heute C Uprimny 2007 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT J Nucl Med 48 508 518
2. T Belhocine J Foidart P Rigo F Najjar A Thiry P Quatresooz 2002 Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67 Nucl Med Commun 23 727 734
3. H Orlefors A Sundin L Lu K Oberg B Langstrom B Eriksson 2006 Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomography Eur J Nucl Med Mol Imaging 33 60 65
4. F Montravers D Grahek K Kerrou P Ruszniewski V de Beco N Aide 2006 Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med 47 1455 1462
5. WA Breeman M de Jong E de Blois BF Bernard M Konijnenberg EP Krenning 2005 Radiolabelling DOTA-peptides with 68Ga Eur J Nucl Med Mol Imaging 32 478 485
6. A Luxen M Perlmutter GT Bida G Van Moffaert JS Cook N Satyamurthy 1990 Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET Int J Rad Appl Instrum [A] 41 275 281
7. B Eriksson G Kloppel E Krenning H Ahlman U Plockinger B Wiedenmann 2008 Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma Neuroendocrinology 87 8 19
8. M Papotti M Bongiovanni M Volante E Allia S Landolfi L Helboe 2002 Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis Virchows Arch 440 461 475
9. PL Jager R Chirakal CJ Marriott AH Brouwers KP Koopmans KY Gulenchyn 2008 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications J Nucl Med 49 573 586
10. F Saudek CH Brogren S Manohar 2008 Imaging the Beta-cell mass: why and how Rev Diabet Stud 5 6 12
11. V Ambrosini P Tomassetti P Castellucci D Campana G Montini D Rubello 2008 Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours Eur J Nucl Med Mol Imaging 35 1431 1438
12. HJ Timmers M Hadi JA Carrasquillo CC Chen L Martiniova M Whatley 2007 The effects of carbidopa on uptake of 6-18F-fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma J Nucl Med 48 1599 1606